Seizert Capital Partners’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,551
Closed -$628K 222
2021
Q4
$628K Hold
8,551
0.03% 165
2021
Q3
$779K Sell
8,551
-11,818
-58% -$1.01M 0.04% 149
2021
Q2
$1.28M Buy
20,369
+1,786
+10% +$66K 0.06% 125
2021
Q1
$503K Hold
18,583
0.03% 135
2020
Q4
$340K Buy
+18,583
New +$334K 0.02% 142

Other funds holding ASTH

Seizert Capital Partners's ASTH Position: Q1 2022 in Review

Seizert Capital Partners sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 8,551 shares — an estimated $628K sold.

Seizert Capital Partners first reported a position in ASTH in Q4 2020 and held it in 5 quarters. The position peaked at $1.28M in Q2 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Seizert Capital Partners reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 8,551 Astrana Health shares in Q1 2022, an estimated $628K.
  • Seizert Capital Partners first reported a position in Astrana Health in Q4 2020 and held it in 5 quarters.
  • Seizert Capital Partners's Astrana Health position peaked at $1.28M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Seizert Capital Partners's 13F filing for Q1 2022, filed 3 May 2022.